Cargando…

A strategy based on nucleotide specificity leads to a subfamily-selective and cell-active inhibitor of N (6)-methyladenosine demethylase FTO

The AlkB family of nucleic acid demethylases are of intense biological and medical interest because of their roles in nucleic acid repair and epigenetic modification. However their functional and molecular mechanisms are unclear, hence, there is strong interest in developing selective inhibitors for...

Descripción completa

Detalles Bibliográficos
Autores principales: Toh, Joel D. W., Sun, Lingyi, Lau, Lisa Z. M., Tan, Jackie, Low, Joanne J. A., Tang, Colin W. Q., Cheong, Eleanor J. Y., Tan, Melissa J. H., Chen, Yun, Hong, Wanjin, Gao, Yong-Gui, Woon, Esther C. Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Royal Society of Chemistry 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424463/
https://www.ncbi.nlm.nih.gov/pubmed/28553460
http://dx.doi.org/10.1039/c4sc02554g
_version_ 1783235142956875776
author Toh, Joel D. W.
Sun, Lingyi
Lau, Lisa Z. M.
Tan, Jackie
Low, Joanne J. A.
Tang, Colin W. Q.
Cheong, Eleanor J. Y.
Tan, Melissa J. H.
Chen, Yun
Hong, Wanjin
Gao, Yong-Gui
Woon, Esther C. Y.
author_facet Toh, Joel D. W.
Sun, Lingyi
Lau, Lisa Z. M.
Tan, Jackie
Low, Joanne J. A.
Tang, Colin W. Q.
Cheong, Eleanor J. Y.
Tan, Melissa J. H.
Chen, Yun
Hong, Wanjin
Gao, Yong-Gui
Woon, Esther C. Y.
author_sort Toh, Joel D. W.
collection PubMed
description The AlkB family of nucleic acid demethylases are of intense biological and medical interest because of their roles in nucleic acid repair and epigenetic modification. However their functional and molecular mechanisms are unclear, hence, there is strong interest in developing selective inhibitors for them. Here we report the identification of key residues within the nucleotide-binding sites of the AlkB subfamilies that likely determine their substrate specificity. We further provide proof of principle that a strategy exploiting these inherent structural differences can enable selective and potent inhibition of the AlkB subfamilies. This is demonstrated by the first report of a subfamily-selective and cell-active FTO inhibitor 12. The distinct selectivity of 12 for FTO against other AlkB subfamilies and 2OG oxygenases shall be of considerable interest with regards to its potential use as a functional probe. The strategy outlined here is likely applicable to other AlkB subfamilies, and, more widely, to other 2OG oxygenases.
format Online
Article
Text
id pubmed-5424463
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Royal Society of Chemistry
record_format MEDLINE/PubMed
spelling pubmed-54244632017-05-26 A strategy based on nucleotide specificity leads to a subfamily-selective and cell-active inhibitor of N (6)-methyladenosine demethylase FTO Toh, Joel D. W. Sun, Lingyi Lau, Lisa Z. M. Tan, Jackie Low, Joanne J. A. Tang, Colin W. Q. Cheong, Eleanor J. Y. Tan, Melissa J. H. Chen, Yun Hong, Wanjin Gao, Yong-Gui Woon, Esther C. Y. Chem Sci Chemistry The AlkB family of nucleic acid demethylases are of intense biological and medical interest because of their roles in nucleic acid repair and epigenetic modification. However their functional and molecular mechanisms are unclear, hence, there is strong interest in developing selective inhibitors for them. Here we report the identification of key residues within the nucleotide-binding sites of the AlkB subfamilies that likely determine their substrate specificity. We further provide proof of principle that a strategy exploiting these inherent structural differences can enable selective and potent inhibition of the AlkB subfamilies. This is demonstrated by the first report of a subfamily-selective and cell-active FTO inhibitor 12. The distinct selectivity of 12 for FTO against other AlkB subfamilies and 2OG oxygenases shall be of considerable interest with regards to its potential use as a functional probe. The strategy outlined here is likely applicable to other AlkB subfamilies, and, more widely, to other 2OG oxygenases. Royal Society of Chemistry 2015-01-01 2014-09-22 /pmc/articles/PMC5424463/ /pubmed/28553460 http://dx.doi.org/10.1039/c4sc02554g Text en This journal is © The Royal Society of Chemistry 2014 http://creativecommons.org/licenses/by/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution 3.0 Unported License (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Chemistry
Toh, Joel D. W.
Sun, Lingyi
Lau, Lisa Z. M.
Tan, Jackie
Low, Joanne J. A.
Tang, Colin W. Q.
Cheong, Eleanor J. Y.
Tan, Melissa J. H.
Chen, Yun
Hong, Wanjin
Gao, Yong-Gui
Woon, Esther C. Y.
A strategy based on nucleotide specificity leads to a subfamily-selective and cell-active inhibitor of N (6)-methyladenosine demethylase FTO
title A strategy based on nucleotide specificity leads to a subfamily-selective and cell-active inhibitor of N (6)-methyladenosine demethylase FTO
title_full A strategy based on nucleotide specificity leads to a subfamily-selective and cell-active inhibitor of N (6)-methyladenosine demethylase FTO
title_fullStr A strategy based on nucleotide specificity leads to a subfamily-selective and cell-active inhibitor of N (6)-methyladenosine demethylase FTO
title_full_unstemmed A strategy based on nucleotide specificity leads to a subfamily-selective and cell-active inhibitor of N (6)-methyladenosine demethylase FTO
title_short A strategy based on nucleotide specificity leads to a subfamily-selective and cell-active inhibitor of N (6)-methyladenosine demethylase FTO
title_sort strategy based on nucleotide specificity leads to a subfamily-selective and cell-active inhibitor of n (6)-methyladenosine demethylase fto
topic Chemistry
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5424463/
https://www.ncbi.nlm.nih.gov/pubmed/28553460
http://dx.doi.org/10.1039/c4sc02554g
work_keys_str_mv AT tohjoeldw astrategybasedonnucleotidespecificityleadstoasubfamilyselectiveandcellactiveinhibitorofn6methyladenosinedemethylasefto
AT sunlingyi astrategybasedonnucleotidespecificityleadstoasubfamilyselectiveandcellactiveinhibitorofn6methyladenosinedemethylasefto
AT laulisazm astrategybasedonnucleotidespecificityleadstoasubfamilyselectiveandcellactiveinhibitorofn6methyladenosinedemethylasefto
AT tanjackie astrategybasedonnucleotidespecificityleadstoasubfamilyselectiveandcellactiveinhibitorofn6methyladenosinedemethylasefto
AT lowjoanneja astrategybasedonnucleotidespecificityleadstoasubfamilyselectiveandcellactiveinhibitorofn6methyladenosinedemethylasefto
AT tangcolinwq astrategybasedonnucleotidespecificityleadstoasubfamilyselectiveandcellactiveinhibitorofn6methyladenosinedemethylasefto
AT cheongeleanorjy astrategybasedonnucleotidespecificityleadstoasubfamilyselectiveandcellactiveinhibitorofn6methyladenosinedemethylasefto
AT tanmelissajh astrategybasedonnucleotidespecificityleadstoasubfamilyselectiveandcellactiveinhibitorofn6methyladenosinedemethylasefto
AT chenyun astrategybasedonnucleotidespecificityleadstoasubfamilyselectiveandcellactiveinhibitorofn6methyladenosinedemethylasefto
AT hongwanjin astrategybasedonnucleotidespecificityleadstoasubfamilyselectiveandcellactiveinhibitorofn6methyladenosinedemethylasefto
AT gaoyonggui astrategybasedonnucleotidespecificityleadstoasubfamilyselectiveandcellactiveinhibitorofn6methyladenosinedemethylasefto
AT woonesthercy astrategybasedonnucleotidespecificityleadstoasubfamilyselectiveandcellactiveinhibitorofn6methyladenosinedemethylasefto
AT tohjoeldw strategybasedonnucleotidespecificityleadstoasubfamilyselectiveandcellactiveinhibitorofn6methyladenosinedemethylasefto
AT sunlingyi strategybasedonnucleotidespecificityleadstoasubfamilyselectiveandcellactiveinhibitorofn6methyladenosinedemethylasefto
AT laulisazm strategybasedonnucleotidespecificityleadstoasubfamilyselectiveandcellactiveinhibitorofn6methyladenosinedemethylasefto
AT tanjackie strategybasedonnucleotidespecificityleadstoasubfamilyselectiveandcellactiveinhibitorofn6methyladenosinedemethylasefto
AT lowjoanneja strategybasedonnucleotidespecificityleadstoasubfamilyselectiveandcellactiveinhibitorofn6methyladenosinedemethylasefto
AT tangcolinwq strategybasedonnucleotidespecificityleadstoasubfamilyselectiveandcellactiveinhibitorofn6methyladenosinedemethylasefto
AT cheongeleanorjy strategybasedonnucleotidespecificityleadstoasubfamilyselectiveandcellactiveinhibitorofn6methyladenosinedemethylasefto
AT tanmelissajh strategybasedonnucleotidespecificityleadstoasubfamilyselectiveandcellactiveinhibitorofn6methyladenosinedemethylasefto
AT chenyun strategybasedonnucleotidespecificityleadstoasubfamilyselectiveandcellactiveinhibitorofn6methyladenosinedemethylasefto
AT hongwanjin strategybasedonnucleotidespecificityleadstoasubfamilyselectiveandcellactiveinhibitorofn6methyladenosinedemethylasefto
AT gaoyonggui strategybasedonnucleotidespecificityleadstoasubfamilyselectiveandcellactiveinhibitorofn6methyladenosinedemethylasefto
AT woonesthercy strategybasedonnucleotidespecificityleadstoasubfamilyselectiveandcellactiveinhibitorofn6methyladenosinedemethylasefto